$33.4B
$1.78 Million
0.0% of portfolio
163
Q3 2025
Added 59.8%
$481M
$4.73 Million
0.0% of portfolio
163
Q4 2025
Added 114.47%
$1.66B
$2.56 Million
0.0% of portfolio
165
Q4 2025
Added 77.42%
Inhibrx Biosciences Inc Com
-
$13 Million
0.0% of portfolio
-
Q4 2025
Added 18.71%
$326M
$3.73 Million
0.0% of portfolio
165
Q4 2025
Reduced 53.52%
$108M
$178,000
0.0% of portfolio
165
Q4 2025
New
$232M
$3.78 Million
0.0% of portfolio
166
Q4 2025
Added 133.8%
-
$6.37 Million
0.0% of portfolio
-
Q4 2025
Added 82.42%
$313M
$3.81 Million
0.0% of portfolio
167
Q4 2025
Reduced 42.01%
$1.53B
$28.5 Million
0.0% of portfolio
168
Q4 2025
Added 7.01%
-
$1.92 Million
0.0% of portfolio
-
Q2 2025
New
$0
$5.53 Million
0.0% of portfolio
168
Q1 2025
Reduced 96.13%
Madison Square Garden Entmt Com Cl A
-
$9.05 Million
0.0% of portfolio
-
Q4 2025
Added 43.59%
$722M
$8.08 Million
0.0% of portfolio
168
Q4 2025
Reduced 30.86%
Critical Metals Corp Pubco Ord Shs
-
$1.17 Million
0.0% of portfolio
-
Q4 2025
Reduced 36.94%
$4.52B
$49.6 Million
0.0% of portfolio
169
Q4 2025
Reduced 11.52%
$230M
$277,000
0.0% of portfolio
169
Q4 2025
New
Resolute Hldgs Mgmt Inc Com
-
$34.9 Million
0.0% of portfolio
-
Q4 2025
Added 6.96%
-
$15.4 Million
0.0% of portfolio
-
Q3 2025
New
$2.39B
$4.66 Million
0.0% of portfolio
171
Q4 2025
Reduced 16.99%
$88.1M
$1.29 Million
0.0% of portfolio
171
Q4 2025
Added 94.32%
Maze Therapeutics Inc Com
-
$7.13 Million
0.0% of portfolio
-
Q4 2025
Added 8.18%
$359M
$1.37 Million
0.0% of portfolio
172
Q4 2025
Added 290.91%
$327M
$3.26 Million
0.0% of portfolio
174
Q4 2025
Added 117.5%
$1.65B
$9.49 Million
0.0% of portfolio
174
Q4 2025
Added 107.14%
Voyager Technologies Inc Com Cl A
-
$4.55 Million
0.0% of portfolio
-
Q4 2025
New
$989M
$6.58 Million
0.0% of portfolio
175
Q4 2025
Added 6.06%
-
$234,000
0.0% of portfolio
-
Q4 2025
New
Forge Global Holdings Inc Com Shs
-
$7.84 Million
0.0% of portfolio
-
Q4 2025
Reduced 32.05%
$845M
$5.93 Million
0.0% of portfolio
176
Q4 2025
Added 282.61%
$7.04B
$1.01 Million
0.0% of portfolio
177
Q3 2025
New
Sionna Therapeutics Inc Com
-
$7.28 Million
0.0% of portfolio
-
Q4 2025
Added 15.69%
-
$956,000
0.0% of portfolio
-
Q4 2025
Reduced 86.69%
$124M
$3.44 Million
0.0% of portfolio
177
Q4 2025
Added 105.81%
$106M
$819,000
0.0% of portfolio
178
Q4 2025
New
$175M
$2.92 Million
0.0% of portfolio
178
Q4 2025
Reduced 9.64%
$293M
$1.23 Million
0.0% of portfolio
178
Q4 2025
New
$0
$49.7 Million
0.0% of portfolio
178
Q2 2025
Added 71.15%
$330M
$2.21 Million
0.0% of portfolio
179
Q4 2025
Added 225.45%
$1.42B
$2.54 Million
0.0% of portfolio
179
Q4 2025
Added 13.29%
Nebius Group N V Shs Class A
-
$15 Million
0.0% of portfolio
-
Q1 2025
Reduced 95.26%
$1.85B
$4.7 Million
0.0% of portfolio
179
Q3 2025
Added 84.54%
-
$6.5 Million
0.0% of portfolio
-
Q4 2025
Reduced 2.19%
$203M
$891,000
0.0% of portfolio
180
Q4 2025
Reduced 72.35%
-
$11.6 Million
0.0% of portfolio
-
Q4 2025
New
$2.02B
$2.62 Million
0.0% of portfolio
180
Q4 2025
Reduced 1.64%
$661M
$2.25 Million
0.0% of portfolio
180
Q4 2025
Added 160.87%
$348M
$2.98 Million
0.0% of portfolio
180
Q4 2025
Reduced 7.69%
$340M
$3.38 Million
0.0% of portfolio
181
Q4 2025
Added 34.07%
$1.76B
$3.17 Million
0.0% of portfolio
181
Q1 2025
Reduced 94.02%